Cargando…
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
Vogt-Koyanagi-Harada (VKH) disease is a multisystem syndrome characterized by ocular (uveitis and retinal detachment), neurological (headache, tinnitus, and meningitis), and integumentary (vitiligo, alopecia, and poliosis) involvement. Although the pathogenesis of VKH disease is not well understood,...
Autores principales: | Lim, Jae Hee, Lee, Yun Nah, Kim, Young Seok, Kim, Sang Gyune, Jeong, Seung Won, Jang, Jae Young, Kim, Hong Soo, Lee, Sae Hwan, Park, Tae Kwann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304626/ https://www.ncbi.nlm.nih.gov/pubmed/21494079 http://dx.doi.org/10.3350/kjhep.2011.17.1.61 |
Ejemplares similares
-
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
por: Jung, Hee Jae, et al.
Publicado: (2014) -
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021) -
Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023)